Robot maker · registered
Medical Microinstruments
Symani Surgical System is a collaborative teleoperation robotic platform for open microsurgery; computer-assisted tremor reduction and motion scaling enable anastomosis of vessels as small as 0.2 mm; surgeon-in-the-loop control with wristed NanoWrist microinstruments (world's smallest wristed robotic instruments); CE marked 2019, FDA De Novo authorization April 2024; expanding toward intraoperative AI per CEO roadmap.
Company overview
Identity and operating footprint
Robot models
Specifications remain vendor-claimed
Symani Surgical System
- World's smallest wristed robotic microinstruments
vendor-stated instrument scale enabling operation within sub-millimetre anatomical spaces not accessible to standard surgical robots
Claim source - 100% first-attempt patency on 0.2 mm vessels vs. 80% manual baseline
preclinical study result cited by vendor demonstrating vascular anastomosis success rate superiority over unaided human technique
Claim source
Deployment log
Announced and cited only
Funding history
Publicly announced rounds
Series C
Andera Partners, BioStar, Deerfield Management, Fidelity Management & Research Company, Fountain Healthcare Partners, Panakès Partners, RA Capital Management, Sambatech
Round sourceSeries B
Andera Partners, BioStar, Deerfield Management, Fountain Healthcare Partners, Panakès Partners, RA Capital Management, Sambatech
Round sourceSeries A
Andera Partners, Fountain Healthcare Partners, Panakès Partners, Sambatech
Round sourceSeed
Round sourceCompany timeline
Milestones and announcements
Source ledger
15 unique public sources